Thank you for all the essential research to date on Alpha1 Antitrypsin Deficiency!
With our discoveries, we will keep researchers busy for the foreseeable future investigating the great value of Alpha1 Antitrypsin and how to overcome the medical difficulties that Alpha1 Antitrypsin Deficiency presents to those who suffer from the deficiency!
The Mark Egly Foundation is working tirelessly to accelerate research to find positive outcomes with cures and prevention of the disease listed in Mark's patent filing.